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Abstract 
X-ray structures of the methyiiodide salts of (N-(,B-phenylethyl)piperidine (N-(,B-phenyl-
ethyl )-N-methyl-piperidiniumiodide) and dimethylphenyl-piperidinomethyl-silane (N-
methyl-N-(phenyldimethylsilyl )-methyl- piperidinium iodide) are reported. 
Keywords: structure of methyl-iodide salts of dimethylphenylpiperidinomethylsilane and 
N -(,B-phenylethyl )piperidine; sila-pharmaca. 
Introduction 
Molecules containing the phenylethylamine skeleton (Ph-C-C-N =) pos-
sess a wide range of pharmacological properties. Phenylethylamine itself 
has psychostimulant effect, which can be tuned and modified by a variety 
of substituents [1, 2]. We have synthesized N-(,6-phenylethyl)piperidine 
(I) and its sila-analogue (Il). PORSZASZ et al. showed that I has enhanced 
curare-like effect [3]. The sila-analogue is different by one -CH2- group 
from the compound (Ill) which was found to have as effective tumor-
inhibiting properties as 5-fluorouracil though it is toxic [4]. The methylio-
dide salts were prepared for X-ray structure determination. 
Experimental 
Synthesis 
Several routes are known for the synthesis of N-(,6-phenylethyl)piperidine 
(I) [5-9]. The method of N AMYOTKIN et al. [9] has been chosen, starting 
1 Part I.: [1] 
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from piperidine and butyllithium and finally reacting it with styrene. The 
quaternary ammonium salt was yielded by methyliodide. 
Dimethylphenylpiperidinomethylsilane (II) was obtained from phenyl-
dimethylchloromethylsilane with piperidine and the salt was formed with 
methyliodide [1]. 
Crystal Structure Analysis 
Crystal data and data collection parameters are summarized in Table 1. 
Table 1 
Crystal data, data collection parameters and least-squares parameters 
Empirical formula 
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X-ray measurements were performed on a computer-controlled four-
circle Enraf-Nonius CAD4 diffractometer with monochromated Cu-Ko:-
radiation (.A = 1.5418 A), at room temperature. Approximate crystal sizes 
were 0.25 x 0.25 X 0.30mm (1) and 0.15 x 0.20 x 0.30 mm (II). Unit cell 
parameters were determined by least-squares from the setting angles of 25 
(30 < e < 33°) carefully centered refiexions. Three intensity check refiexions 
were measured every hour and these indicated a 5.9% total loss of intensity 
for n. A linear decay correction was therefore applied for the intensity data 
of II (the correction factors on intensity ranged from 0.983 to 1.086 with 
an average value of 1.030). 
The structures were solved by the heavy atom method and weighted 
Fourier syntheses and were refined by full matrix anisotropic least-squares. 
At the end of isotropic refinements an empirical spherical absorption cor-
rection [10] was applied for both crystals. The minimum, maximum, and 
average relative transmission coefficients were as follows: 0.866, 1.552, 1.049 
for 1, and 0.427, 1.599, 1.009 for 11. Hydrogen atomic positions were calcu-
lated from assumed geometries and they were added as fixed contributions 
(B H = B eq ,c+l A 2) to structure factor calculations. Final atomic parameters 
are given in Tables 2 and 3 2 . Atomic scattering factors were taken from 
[11]. 
The molecular diagrams are depicted in Figs. 1 and 2, the relevant 
data of the molecular geometries are shown in Tables 4 and 5. 
2Lists of observed and calculated structure factors and anisotropic thermal para-
meters can be obtained from the authors. 
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Fig. 1. The molecular diagram of compound I 
Fig. 2. The molecular diagram of compound II 
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Table 2 
Final atomic coordinates and B( eq) (B for the hydrogen atoms) 
(A2) values for compound I 
Atom x/a y/b z/c B(eq)/B 
I OA1785(6) 0.38978(3) 0.84830(2) 2.55(1) 
NI 0.0664(7) 0.6587(3) 0.6391(2) 1.4(1 ) 
C2 -0.1209(8) 0.5994(4) 0.6323(3) 1.9(2) 
C3 -0.158(1) 0.5221(5) 0.6998(4) 2.8(2) 
C4 -0.157(1) 0.5841(6) 0.7759(4) 3.4(2) 
C5 0.027(1 ) 0.6481(5) 0.7852(3) 2.8(2) 
C6 0.0681(9) 0.7222(4) 0.7163(3) 1.8(1) 
C7 0.080(1) 0.7443(5) 0.5754(3) 3.0(2) 
C8 0.2331(8) 0.5810(4) 0.6346(3) 1.7(1) 
C9 0.225(1 ) OA991(5) 0.5662(3) 2.9(2) 
C10 OA04(1) 0,4307{ 4) 0.5617(2) 1.7{ 1) 
C11 OA34(1) 0.3423(5) 0.6122(3) 2.4(2) 
C12 0.591(1) 0.2747(4) 0.6049(3) 2.8(2) 
C13 O. 724(1) 0.2984(5) 0.5482(3) 3.0(2) 
C14 0.698{1 ) 0.3891(5) OA982(3) 2.8(2) 
C15 0.539{1 ) 0.4532(5) 0.5054(3) 2.6(2) 
H2a -0.218 0.654 0.630 2.9 
H2b -0.122 0.557 0.586 2.9 
H3a -0.278 0.488 0.693 3.8 
H3b -0.063 OA66 0.701 3.8 
H4a -0.260 0.635 0.777 4A 
H4b -0.170 0.532 0.818 4A 
H5a 0.019 0.693 0.831 3.8 
H5b 0.127 0.596 0.791 3.8 
H6a 0.189 0.755 0.723 2.8 
H6b -0.025 0.779 0.714 2.8 
H7a 0.198 0.782 0.579 4.0 
H7b 0.072 0.708 0.526 4.0 
H7c -0.020 0.797 0.581 4.0 
H8a 0.344 0.625 0.630 2.7 
H8b 0.239 0.539 0.682 2.7 
H9a 0.121 OA50 0.573 3.9 
H9b 0.211 0.540 0.519 3.9 
H11 0.345 0.328 0.652 2.7 
H12 0.608 0.212 0.639 2.7 
H13 0.833 0.253 0.543 2.7 
H14 0.789 OA06 OA60 2.7 
H15 0.521 0.515 0.471 2.7 
The equivalent isotropic temperature factor is defined as 
B(eq) =4/3 trace (ft G) where ft is the thermal 
motion tensor and G is the direct metric tensor. 
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Table 3 
Final atomic coordinates and B( eq) (B for the hydrogen atoms) 
(A2) for compound II 
Atom x/a y/b z/c /E 
0 0.17225(3) 0 4.51(1) 
Si 0.4174(3) 0.0703(1) 0.3644(2) 3.32(5) 
N 0.571(1) 0.18010(3) 0.2488(7) 3.7(2) 
Cl 0.415(1) -0.0029(,5) 0.269(1 ) 5.5(3) 
C2 0.199(1) 0.0730(6) 0.409( 1) 5.3(3) 
C3 0.417(1) 0.1553( 4) 0.2929(8) 3.8(2) 
C4 0.610(1) 0.0636(3) 0.4958(7) 2.7(1) 
C5 0.623(1) 0.1110( 4) 0.5850(7) 3.6(2) 
C6 O. 757( 1) 0.1062(5) 0.6857(8) 4.1(2) 
C7 0.885( 1) 0.0566(5) 0.7009(9) 5.2(2) 
C8 0.882( 1) 0.0101(5) 0.616(1) 5.3(3) 
C9 0.745( 1) 0.0130( 4) 0.5150(9) 4.0(2) 
C10 0 .. 595(1) 0.1342(6) 0.158(1) 5.1(3) 
Cll 0.515(1) 0.2497(5) 0.1977(9) 4.9(2) 
C12 0.664(2) 0.2837(6) 0.159(1) 5.6(3) 
C13 0.837(2) 0.2931(8) 0.265(1) 6.2( 4) 
C14 0.893( 1) 0.2219(7) 0.312(1) 5.7(4) 
C15 0.744(1) 0.1886(5) 0.3426(8) 4.2(2) 
H1a 0.316 0.001 0.203 6.6 
H1b 0.526 -0.004 0.248 6.6 
H1c 0.401 -0.044 0.308 6.6 
H2a 0.098 0.077 0.344 6.3 
H2b 0.188 0.033 0.450 6.3 
H2c 0.201 0.111 0.457 6.3 
H3a 0.312 0.15.5 0.230 4.7 
H3b 0.403 0.188 0.347 4.7 
H5 0.537 0.147 0.575 3.7 
H6 0.760 0.138 0.745 3.7 
H7 0.977 0.0.54 0.771 3.7 
H8 0.973 -0.024 0.628 3.7 
H9 0.741 -0.020 0.457 3.7 
HI0a 0.692 0.150 0.130 6.1 
HI0b 0.622 0.090 0.188 6.1 
H10c 0.486 0.133 0.097 6.1 
Hlla 0.412 0.245 0.134 5.8 
Hllb 0.486 0.277 0.254 5.8 
H12a 0.625 0.327 0.127 6.6 
H12b 0.698 0.257 0.103 6.6 
H13a 0.808 0.321 0.321 7.3 
H13b 0.936 0.314 0.242 7.3 
H14a 0.993 0.225 0.377 6.6 
H14b 0.925 0.196 0.255 6.6 
H15a 0.71.5 0.214 0.402 5.2 
H15b 0.784 0.145 0.371 5.2 
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Table 4 
Bond distances (A), bond angles (0) and relevant torsion angles for I 
Bond lengths (A) 
NI-C2 1.510(8) C3-C4 1.50(1) ClO-C11 1.384(8) 
NI-C6 1.527(7) C4-C5 1.52(1) CIO-CI5 1.39(1) 
NI-C7 1.501(8) C5-C6 1.506(9) Cll-CI2 1.38(1) 
NI-C8 1.504(8) C8-C9 1.531(8) C12-C13 1.38(1) 
C2-C3 1.505(9) C9-CI0 1.51(1} C13-C14 1.394(9) 
C14-C15 1.37(1) 








C2-C3-C4 111 (1) 
C3-C4-C5 11 O( 1) 
C4-C5-C6 112( 1) 
NI -C6 -C5 
NI -C8 -C9 
C8 -C9 -CIO 
C9 -ClO -Cll 
C9 -CI0 -C15 
Cll -C10 -C15 
CI0 -Cll -C12 
Cl1 -C12 -C13 
C12 -C13 -C14 
C13 -C14 -C15 
ClO -C15 -C14 












C4-C3-C2-Nl 59(1) C8 -NI -C2-C3 65.3(9) 
-69.3(8) C4-C5-C6-Nl -55(1) C8 -NI -C6-C5 
C5-C4-C3-C2 -55(1) C9 -C8 -NI-C2 
C5-C6-NI-C2 54.9(9) C9 -C8 -NI-C6 
C6-NI-C2-C3 -57.0(8) C9 -C8 -NI-C7 
C6-C5-C4-C3 53( 1 ) C 10 -C9 -C8-NI 
C7-NI-C2-C3 -173(1) Cll -ClO -C9-C8 
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Table 5 
Bond distances (A), bond angles (0) and relevant torsion angles for II 
Bond lengths 
SI-Cl 1.85(1) 
SI-C2 1.89( 1) 
SI-C3 1.89( 1) 
SI-C4 1.865(8) 
N -C3 1.50(1) 
N -ClO 1.48(2) 
Bond angles 
Cl -SI -C2 
Cl -SI -C3 
Cl -SI -C4 
C2 -SI -C3 
C2 -SI -C4 
C3 -SI -C4 
C3 -N -ClO 
C3 -N -Cll 






Cl -SI -C3-N 
C2 -SI -C3-N 
C4 -SI -C3-N 
C5 -C4 -SI-Cl 
C5 -C4 -SI-C2 
C5 -C4 -SI-C3 
C9 -C4 -SI-Cl 
C9 -C4 -SI-C2 
C9 -C4 -SI-C3 
CIO-N -C3-SI 
Cll-N -C3-SI 
N -Cll 1.52(1) 
N -C15 1.51(1) 
C4-C5 1.42( 1) 
C4-C9 1.41(1) 
C5-C6 1.38(1) 





































SI -C4 -C5 
SI -C4 -C9 
C5 -C4 -C9 
C4 -C5 -C6 
C5 -C6 -C7 
C6 -C7 -C8 
C7 -C8 -C9 
C4 -C9 -C8 
N -Cll-CI2 
C11-C12 -C13 
C12 -C13 -C14 



















C14-C13 -C12 -C11 
C14-C15-N -C3 
C14-C15 -N -CID 
C14-C15 -N -Cll 
C15-N -C3 -SI 
C15-N -Cll-C12 
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Discussion 
Organosilicon compounds with known structures related to II are listed in 
Table 6. Of the organic derivatives, 3-phenethyl-3-azabicyclo(3.2.1)octan-
8-0:-01 (VII), the structure of which has been recently determined [15], 
is worth mentioning. This compound is a derivative of I containing a 
condensed and OH-substituted piperidine ring. 
Table 6 
Related organosilicon compounds 
Compound RI R2 -Cx - Ref-
III CH 3 CH 3 -CH2CH2- [4] 
IV C6 H5 OH -CH20CH2CH2- [12] 
V C6 H5 OH -CH2CH2CH2- [13] 
IV C6H5 OH -CH2CH 2- [14] 
n° CH 3 C H3 -CH2- this work 
• CH31 salt 
Due to the presence of the iodine atoms in both structures, the e.s.d's 
of bonds lengths and angles are rather high. In view of the high uncertain-
ties of the molecular geometry, no significant deviations can be detected 
when the two structures are compared. The piperidine ring, which might 
be the biologically important part of the structures, is of chair conformation 
in both structures eC4 [I] and 4Cl [Il]). 
The overall shape and conformation of the molecules are completely 
different (c.f. Figs. 1 and 2), the solid state conformation, therefore can-
not be directly related to the biological activity. Starting from the final 
atomic coordinates, a molecular mechanic energy minimization was carried 
out using the MM2 program [16]. The refinement, apart from idealizing 
hydrogen atomic positions, slightly changed bond distances, angles, and 
torsion angles, but left the overall conformation intact. 
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